CUSIP 71715X203COM NEWPMCBQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
28 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Citadel Advisors LLC | 229.7K | $166.3K | +215.2K | Added |
| 2 | Geode Capital Management, LLC | 123.8K | $89.7K | −2.8K | Reduced |
| 3 | Sabby Management, LLC | 100.0K | $72.4K | +100.0K | New |
| 4 | Renaissance Technologies LLC | 94.0K | $68.1K |
| +14.0K |
| Added |
| 5 | Vanguard Group Inc | 74.9K | $54.2K | 0 | Held |
| 6 | Northern Trust Corp | 35.6K | $25.8K | +16.4K | Added |
| 7 | Schonfeld Strategic Advisors LLC | 26.2K | $19.0K | −22 | Reduced |
| 8 | Simplex Trading, LLC | 25.8K | $18.7K | +24.7K | Added |
| 9 | Two Sigma Securities, LLC | 24.6K | $17.8K | +24.6K | New |
| 10 | Xtx Topco Ltd | 24.4K | $17.7K | +24.4K | New |
See every fund holding Pharmacyte Biotech Inc, with full quarter-over-quarter share changes.
Unlock all holders